Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Regional Health Properties A Pref | RHE-A | Jan 21, 2025 | 0.83 | +5.98 |
Regional Management | RM | Jan 21, 2025 | 35.67 | -0.06 |
Regions Financial | RF | Jan 21, 2025 | 24.65 | +1.86 |
Regions Financial B Pref | RF-B | Jan 21, 2025 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | Jan 21, 2025 | 24.80 | -0.04 |
Regions Financial E Pref | RF-E | Jan 21, 2025 | 18.50 | +2.04 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | Jan 21, 2025 | 25.66 | +0.27 |
Regis | RGS | Jan 21, 2025 | 23.71 | -3.22 |
Regulus Therapeutics | RGLS | Jan 21, 2025 | 1.26 | +1.61 |
Rein Therapeutics | RNTX | Jan 21, 2025 | 1.94 | 0.00 |
Reinsurance Group of America | RGA | Jan 21, 2025 | 224.13 | +0.52 |
REIT Index ETF Vanguard | VNQ | Jan 21, 2025 | 91.33 | +1.87 |
Reitar Logtech | RITR | Jan 21, 2025 | 3.89 | +9.27 |
Rekor Systems | REKR | Jan 21, 2025 | 1.57 | -1.88 |
Relay Therapeutics | RLAY | Jan 21, 2025 | 4.66 | +4.48 |
Reliance | RS | Jan 21, 2025 | 290.47 | +0.84 |
Reliance Global | RELI | Jan 21, 2025 | 2.18 | +1.87 |
Relmada Therapeutics | RLMD | Jan 21, 2025 | 0.37 | -0.72 |
RELX ADR | RELX | Jan 21, 2025 | 49.55 | +2.86 |
Remitly Global | RELY | Jan 21, 2025 | 23.14 | -0.52 |
Renaissance Ipo ETF | IPO | Jan 21, 2025 | 46.61 | +1.40 |
RenaissanceRe | RNR | Jan 21, 2025 | 257.22 | -0.09 |
RenaissanceRe G Pref | RNR-G | Jan 21, 2025 | 16.78 | +1.57 |
RenaissanceRe Holding F Pref | RNR-F | Jan 21, 2025 | 23.26 | +1.71 |
Renasant | RNST | Jan 21, 2025 | 36.78 | +1.29 |
ReNew Energy Global A Shares | RNW | Jan 21, 2025 | 6.77 | -0.15 |
Renn Fund | RCG | Jan 21, 2025 | 2.81 | +6.04 |
Renovaro Biosciences | RENB | Jan 21, 2025 | 0.71 | +1.12 |
RenovoRx | RNXT | Jan 21, 2025 | 1.54 | +2.67 |
Rent The Runway A | RENT | Jan 21, 2025 | 8.69 | +1.52 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.